BWX Technologies Poised For Growth In Nuclear Power, Medical Radioisotopes Says Analyst
1. Seaport Global's Jeff Campbell initiated coverage on BWXT with a Buy rating. 2. BWXT monopolizes U.S. Navy nuclear reactor components, ensuring steady revenues. 3. Management improves value through ancillary offerings alongside core services. 4. Expansion in Canada and the health sector enhances growth opportunities. 5. Campbell's projections include $602.1 million in Q1 revenue at $0.60 EPS.